Nexus Surgical and Medicare Limited (BOM:538874)
19.49
+1.30 (7.15%)
At close: Aug 21, 2026
BOM:538874 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 5.04 | 3.31 | 2.34 | 6.51 | 1.08 |
Short-Term Investments | - | 0.43 | 0.43 | 0.43 | 0.43 | 0.43 |
Cash & Short-Term Investments | 5.47 | 5.47 | 3.74 | 2.77 | 6.94 | 1.5 |
Cash Growth | 46.31% | 46.32% | 35.11% | -60.12% | 361.49% | -33.06% |
Accounts Receivable | - | 13.24 | 13.38 | 7.52 | 0.43 | - |
Receivables | - | 23.49 | 13.38 | 8.55 | 0.43 | 10.13 |
Inventory | - | 3.65 | 4.29 | 4.02 | 0.71 | 4.26 |
Other Current Assets | - | 3.61 | 1.03 | 2.18 | 0.76 | 2.07 |
Total Current Assets | - | 36.23 | 22.43 | 17.52 | 8.84 | 17.96 |
Property, Plant & Equipment | - | 0.2 | 0.24 | 0.21 | 0.2 | 0.15 |
Long-Term Deferred Tax Assets | - | 0.08 | 0.07 | 0.08 | 0.09 | 0.11 |
Other Long-Term Assets | - | 0 | - | 0.26 | 0.03 | 1.83 |
Total Assets | - | 36.51 | 22.75 | 18.06 | 9.16 | 20.04 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 15.95 | 11.78 | 12.37 | 5.58 | 17.78 |
Accrued Expenses | - | - | 0.14 | 0.03 | 0.05 | 0.44 |
Current Income Taxes Payable | - | - | 0.19 | - | - | - |
Other Current Liabilities | - | 2.56 | - | - | - | - |
Total Current Liabilities | - | 18.51 | 12.11 | 12.4 | 5.63 | 18.22 |
Other Long-Term Liabilities | - | - | -0 | - | - | - |
Total Liabilities | - | 18.51 | 12.11 | 12.4 | 5.63 | 18.22 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 54.72 | 54.72 | 54.72 | 54.72 | 54.72 |
Retained Earnings | - | -36.72 | -44.08 | -49.06 | -51.19 | -52.9 |
Shareholders' Equity | 18 | 18 | 10.64 | 5.66 | 3.53 | 1.82 |
Total Liabilities & Equity | - | 36.51 | 22.75 | 18.06 | 9.16 | 20.04 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash (Debt) | 5.47 | 5.47 | 3.74 | 2.77 | 6.94 | 1.5 |
Net Cash Growth | 46.31% | 46.32% | 35.11% | -60.12% | 361.49% | -33.06% |
Net Cash Per Share | 1.00 | 1.00 | 0.68 | 0.51 | 1.27 | 0.27 |
Filing Date Shares Outstanding | 5.52 | 5.45 | 5.47 | 5.47 | 5.47 | 5.47 |
Total Common Shares Outstanding | 5.52 | 5.45 | 5.47 | 5.47 | 5.47 | 5.47 |
Working Capital | - | 17.72 | 10.33 | 5.12 | 3.21 | -0.26 |
Book Value Per Share | 3.30 | 3.30 | 1.94 | 1.03 | 0.65 | 0.33 |
Tangible Book Value | 18 | 18 | 10.64 | 5.66 | 3.53 | 1.82 |
Tangible Book Value Per Share | 3.30 | 3.30 | 1.94 | 1.03 | 0.65 | 0.33 |
Machinery | - | - | 2.97 | 2.9 | 2.87 | 2.81 |